Eosinophil cationic protein: A new biomarker of coronary atherosclerosis

Giampaolo Niccoli, Giuseppe Ferrante, Nicola Cosentino, Micaela Conte, Flavia Belloni, Marcello Marino, Marco Bacà, Rocco Antonio Montone, Vito Sabato, Domenico Schiavino, Giampiero Patriarca, Filippo Crea

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Aims: Coronary atherosclerosis is a chronic inflammatory disease, but different inflammatory biomarkers may reflect different phases of atherosclerotic plaque evolution. We aimed at assessing the role of eosinophil cationic protein (ECP), a sensitive marker of eosinophil activation, and C-reactive protein (CRP) in coronary artery disease (CAD). Methods and results: Consecutive anginal patients with angiographic evidence of CAD [stable angina (SA) or non-ST-elevation acute coronary syndrome (NSTE-ACS)], or with angiographically normal coronary arteries (NCA) were enrolled. The severity of CAD was graded according to Bogaty's score and coronary lesion morphology was defined as smooth or complex. Baseline ECP and high sensitivity CRP were measured in all patients. Of 198 patients (64 ± 10 years, male 74%), 91 had SA, 57 had NSTE-ACS and 50 had NCA. ECP levels were significantly higher in SA [30 μg/L (13.8-46.9), p<0.001] and NSTE-ACS [21.8 μg/L (5.5-46.3), p= 0.016] compared to NCA [9.7 μg/L (6.1-13.6)], without significant difference between SA and NSTE-ACS (p= 0.45). CRP levels were significantly higher in NSTE-ACS [2.38 mg/L (1.11-11.94)] compared to SA [1.48 mg/L (0.82-2.83), p= 0.03], and NCA [1.09 mg/L (0.8-2.1), p<0.001], without significant difference between SA and NCA (p= 0.20). The addition of ECP to main cardiovascular risk factors improved the area under the curve from 0.88 to 0.92, p= 0.007 for the angiographic diagnosis of CAD; further addition of CRP increased the area to 0.94, p= 0.014. At multiple linear regression analysis ECP levels independently predicted CAD severity (p= 0.001), whereas CRP levels independently predicted lesion complexity (p= 0.01). Conclusions: Our study shows that ECP is a marker of CAD and that different inflammatory biomarkers reflect different phases of atherosclerotic plaque evolution.

Original languageEnglish
Pages (from-to)606-611
Number of pages6
JournalAtherosclerosis
Volume211
Issue number2
DOIs
Publication statusPublished - Aug 2010

Fingerprint

Eosinophil Cationic Protein
Staphylococcal Protein A
Stable Angina
Coronary Artery Disease
Biomarkers
Acute Coronary Syndrome
C-Reactive Protein
Coronary Vessels
Atherosclerotic Plaques
Eosinophils
Area Under Curve
Linear Models
Chronic Disease
Regression Analysis

Keywords

  • Atherosclerotic burden
  • C-reactive protein
  • Coronary artery disease
  • Eosinophil cationic protein
  • Non-ST-elevation acute coronary syndromes
  • Plaque morphology

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Eosinophil cationic protein : A new biomarker of coronary atherosclerosis. / Niccoli, Giampaolo; Ferrante, Giuseppe; Cosentino, Nicola; Conte, Micaela; Belloni, Flavia; Marino, Marcello; Bacà, Marco; Montone, Rocco Antonio; Sabato, Vito; Schiavino, Domenico; Patriarca, Giampiero; Crea, Filippo.

In: Atherosclerosis, Vol. 211, No. 2, 08.2010, p. 606-611.

Research output: Contribution to journalArticle

Niccoli, G, Ferrante, G, Cosentino, N, Conte, M, Belloni, F, Marino, M, Bacà, M, Montone, RA, Sabato, V, Schiavino, D, Patriarca, G & Crea, F 2010, 'Eosinophil cationic protein: A new biomarker of coronary atherosclerosis', Atherosclerosis, vol. 211, no. 2, pp. 606-611. https://doi.org/10.1016/j.atherosclerosis.2010.02.038
Niccoli, Giampaolo ; Ferrante, Giuseppe ; Cosentino, Nicola ; Conte, Micaela ; Belloni, Flavia ; Marino, Marcello ; Bacà, Marco ; Montone, Rocco Antonio ; Sabato, Vito ; Schiavino, Domenico ; Patriarca, Giampiero ; Crea, Filippo. / Eosinophil cationic protein : A new biomarker of coronary atherosclerosis. In: Atherosclerosis. 2010 ; Vol. 211, No. 2. pp. 606-611.
@article{1f9ce56f39744c1b9ed03f0ee2e8fb88,
title = "Eosinophil cationic protein: A new biomarker of coronary atherosclerosis",
abstract = "Aims: Coronary atherosclerosis is a chronic inflammatory disease, but different inflammatory biomarkers may reflect different phases of atherosclerotic plaque evolution. We aimed at assessing the role of eosinophil cationic protein (ECP), a sensitive marker of eosinophil activation, and C-reactive protein (CRP) in coronary artery disease (CAD). Methods and results: Consecutive anginal patients with angiographic evidence of CAD [stable angina (SA) or non-ST-elevation acute coronary syndrome (NSTE-ACS)], or with angiographically normal coronary arteries (NCA) were enrolled. The severity of CAD was graded according to Bogaty's score and coronary lesion morphology was defined as smooth or complex. Baseline ECP and high sensitivity CRP were measured in all patients. Of 198 patients (64 ± 10 years, male 74{\%}), 91 had SA, 57 had NSTE-ACS and 50 had NCA. ECP levels were significantly higher in SA [30 μg/L (13.8-46.9), p<0.001] and NSTE-ACS [21.8 μg/L (5.5-46.3), p= 0.016] compared to NCA [9.7 μg/L (6.1-13.6)], without significant difference between SA and NSTE-ACS (p= 0.45). CRP levels were significantly higher in NSTE-ACS [2.38 mg/L (1.11-11.94)] compared to SA [1.48 mg/L (0.82-2.83), p= 0.03], and NCA [1.09 mg/L (0.8-2.1), p<0.001], without significant difference between SA and NCA (p= 0.20). The addition of ECP to main cardiovascular risk factors improved the area under the curve from 0.88 to 0.92, p= 0.007 for the angiographic diagnosis of CAD; further addition of CRP increased the area to 0.94, p= 0.014. At multiple linear regression analysis ECP levels independently predicted CAD severity (p= 0.001), whereas CRP levels independently predicted lesion complexity (p= 0.01). Conclusions: Our study shows that ECP is a marker of CAD and that different inflammatory biomarkers reflect different phases of atherosclerotic plaque evolution.",
keywords = "Atherosclerotic burden, C-reactive protein, Coronary artery disease, Eosinophil cationic protein, Non-ST-elevation acute coronary syndromes, Plaque morphology",
author = "Giampaolo Niccoli and Giuseppe Ferrante and Nicola Cosentino and Micaela Conte and Flavia Belloni and Marcello Marino and Marco Bac{\`a} and Montone, {Rocco Antonio} and Vito Sabato and Domenico Schiavino and Giampiero Patriarca and Filippo Crea",
year = "2010",
month = "8",
doi = "10.1016/j.atherosclerosis.2010.02.038",
language = "English",
volume = "211",
pages = "606--611",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Eosinophil cationic protein

T2 - A new biomarker of coronary atherosclerosis

AU - Niccoli, Giampaolo

AU - Ferrante, Giuseppe

AU - Cosentino, Nicola

AU - Conte, Micaela

AU - Belloni, Flavia

AU - Marino, Marcello

AU - Bacà, Marco

AU - Montone, Rocco Antonio

AU - Sabato, Vito

AU - Schiavino, Domenico

AU - Patriarca, Giampiero

AU - Crea, Filippo

PY - 2010/8

Y1 - 2010/8

N2 - Aims: Coronary atherosclerosis is a chronic inflammatory disease, but different inflammatory biomarkers may reflect different phases of atherosclerotic plaque evolution. We aimed at assessing the role of eosinophil cationic protein (ECP), a sensitive marker of eosinophil activation, and C-reactive protein (CRP) in coronary artery disease (CAD). Methods and results: Consecutive anginal patients with angiographic evidence of CAD [stable angina (SA) or non-ST-elevation acute coronary syndrome (NSTE-ACS)], or with angiographically normal coronary arteries (NCA) were enrolled. The severity of CAD was graded according to Bogaty's score and coronary lesion morphology was defined as smooth or complex. Baseline ECP and high sensitivity CRP were measured in all patients. Of 198 patients (64 ± 10 years, male 74%), 91 had SA, 57 had NSTE-ACS and 50 had NCA. ECP levels were significantly higher in SA [30 μg/L (13.8-46.9), p<0.001] and NSTE-ACS [21.8 μg/L (5.5-46.3), p= 0.016] compared to NCA [9.7 μg/L (6.1-13.6)], without significant difference between SA and NSTE-ACS (p= 0.45). CRP levels were significantly higher in NSTE-ACS [2.38 mg/L (1.11-11.94)] compared to SA [1.48 mg/L (0.82-2.83), p= 0.03], and NCA [1.09 mg/L (0.8-2.1), p<0.001], without significant difference between SA and NCA (p= 0.20). The addition of ECP to main cardiovascular risk factors improved the area under the curve from 0.88 to 0.92, p= 0.007 for the angiographic diagnosis of CAD; further addition of CRP increased the area to 0.94, p= 0.014. At multiple linear regression analysis ECP levels independently predicted CAD severity (p= 0.001), whereas CRP levels independently predicted lesion complexity (p= 0.01). Conclusions: Our study shows that ECP is a marker of CAD and that different inflammatory biomarkers reflect different phases of atherosclerotic plaque evolution.

AB - Aims: Coronary atherosclerosis is a chronic inflammatory disease, but different inflammatory biomarkers may reflect different phases of atherosclerotic plaque evolution. We aimed at assessing the role of eosinophil cationic protein (ECP), a sensitive marker of eosinophil activation, and C-reactive protein (CRP) in coronary artery disease (CAD). Methods and results: Consecutive anginal patients with angiographic evidence of CAD [stable angina (SA) or non-ST-elevation acute coronary syndrome (NSTE-ACS)], or with angiographically normal coronary arteries (NCA) were enrolled. The severity of CAD was graded according to Bogaty's score and coronary lesion morphology was defined as smooth or complex. Baseline ECP and high sensitivity CRP were measured in all patients. Of 198 patients (64 ± 10 years, male 74%), 91 had SA, 57 had NSTE-ACS and 50 had NCA. ECP levels were significantly higher in SA [30 μg/L (13.8-46.9), p<0.001] and NSTE-ACS [21.8 μg/L (5.5-46.3), p= 0.016] compared to NCA [9.7 μg/L (6.1-13.6)], without significant difference between SA and NSTE-ACS (p= 0.45). CRP levels were significantly higher in NSTE-ACS [2.38 mg/L (1.11-11.94)] compared to SA [1.48 mg/L (0.82-2.83), p= 0.03], and NCA [1.09 mg/L (0.8-2.1), p<0.001], without significant difference between SA and NCA (p= 0.20). The addition of ECP to main cardiovascular risk factors improved the area under the curve from 0.88 to 0.92, p= 0.007 for the angiographic diagnosis of CAD; further addition of CRP increased the area to 0.94, p= 0.014. At multiple linear regression analysis ECP levels independently predicted CAD severity (p= 0.001), whereas CRP levels independently predicted lesion complexity (p= 0.01). Conclusions: Our study shows that ECP is a marker of CAD and that different inflammatory biomarkers reflect different phases of atherosclerotic plaque evolution.

KW - Atherosclerotic burden

KW - C-reactive protein

KW - Coronary artery disease

KW - Eosinophil cationic protein

KW - Non-ST-elevation acute coronary syndromes

KW - Plaque morphology

UR - http://www.scopus.com/inward/record.url?scp=77955280733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955280733&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2010.02.038

DO - 10.1016/j.atherosclerosis.2010.02.038

M3 - Article

C2 - 20307883

AN - SCOPUS:77955280733

VL - 211

SP - 606

EP - 611

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 2

ER -